Clinical Trial Update: Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ledipasvir/sofosbuvir with or without ribavirin in hepatitis C patients who failed prior sofosbuvir-based therapy; study terminated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 3 | Status: TERMINATED | Results posted: 2018-04-11